Currently holds positions in Entera Bio Ltd, Entera Bio Ltd and Teva Pharmaceutical Industries Ltd
Position | Company | Period |
---|---|---|
Chairman of the Board | Entera Bio Ltd | Aug. 9, 2018 - |
Independent Chairman of the Board | Entera Bio Ltd | Aug. 9, 2018 - |
Independent Director | Teva Pharmaceutical Industries Ltd | Sept. 1, 2015 - |
Independent Director | Entera Bio Ltd | Jan. 1, 2014 - Aug. 9, 2018 |
Non-Executive Independent Director | COMPUTERSHARE LIMITED | Aug. 1, 2010 - July 23, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-27 | 2023-12-22 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
23,952
+11.8%
0.7117,006 USD |
23,952 +11.8% | 0.71 | 17,006 USD | |
2023-08-23 | 2023-08-21 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
20,000
+10.3%
0.5911,784 USD |
20,000 +10.3% | 0.59 | 11,784 USD | |
2022-11-15 | 2022-11-14 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
4,000
+181.8%
0.592,360 USD |
4,000 +181.8% | 0.59 | 2,360 USD | |
2022-11-15 | 2022-11-14 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
4,000
+181.8%
0.562,240 USD |
4,000 +181.8% | 0.56 | 2,240 USD | |
2022-11-15 | 2022-11-14 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
4,000
+181.8%
0.562,240 USD |
4,000 +181.8% | 0.56 | 2,240 USD | |
2022-11-15 | 2022-11-14 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
4,000
+181.8%
0.562,240 USD |
4,000 +181.8% | 0.56 | 2,240 USD | |
2022-11-15 | 2022-11-14 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
34,000
+21.2%
0.5719,380 USD |
34,000 +21.2% | 0.57 | 19,380 USD | |
2022-07-25 | 2022-07-21 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
19,491
+13.9%
1.6832,803 USD |
19,491 +13.9% | 1.68 | 32,803 USD | |
2022-01-24 | 2022-01-18 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
700
+46.7%
2.811,966 USD |
700 +46.7% | 2.81 | 1,966 USD | |
2022-01-24 | 2022-01-18 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
700
+46.7%
2.781,949 USD |
700 +46.7% | 2.78 | 1,949 USD | |
2022-01-24 | 2022-01-18 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
700
+46.7%
2.811,964 USD |
700 +46.7% | 2.81 | 1,964 USD | |
2022-01-24 | 2022-01-18 |
Entera Bio Ltd
(ENTX)
|
B Purchase |
700
+46.7%
2.801,960 USD |
700 +46.7% | 2.80 | 1,960 USD |